Decellularized Extracellular Matrix for Bioengineering Physiomimetic 3D in Vitro Tumor Models

Area of Science:

• Biomaterials Science
• Cancer Research
• Tissue Engineering

Background:

• Decellularized extracellular matrix (dECM) derived from various tissues offers a promising scaffold for creating physiologically relevant in vitro models.
• The tumor microenvironment, including the extracellular matrix, plays a critical role in cancer progression and therapeutic response.
• Current in vitro models often fail to fully recapitulate the complex interactions within the native tumor microenvironment.

Purpose of the Study:

• To review methodologies for chemically modifying dECM biomaterials for 3D tumor model development.
• To explore advanced bioprocessing techniques for creating organotypic 3D solid tumor models using dECM.
• To discuss the potential of dECM-based platforms for generating predictive data on therapeutic efficacy.

Main Methods:

• Review of current literature on dECM extraction, purification, and chemical modification techniques.
• Analysis of bioprocessing strategies for fabricating 3D solid tumor models from dECM.
• Evaluation of studies utilizing dECM-based platforms for investigating cancer cell-ECM interactions and therapeutic responses.

Main Results:

• dECM provides a biomimetic scaffold that recapitulates key features of the native tumor microenvironment.
• Chemical modifications and advanced bioprocessing enhance the utility of dECM for creating sophisticated 3D tumor models.
• dECM-based models demonstrate potential for more accurate prediction of therapeutic bioperformance compared to traditional models.

Conclusions:

• dECM-based biomaterials are powerful tools for engineering physiomimetic 3D in vitro tumor models.
• These advanced models facilitate the study of dynamic cancer cell-ECM interactions and the tumor microenvironment.
• dECM testing platforms hold significant promise for improving the predictive power of preclinical therapeutic evaluations.